Study Evaluating Management of Patients With Moderate and Severe Psoriasis
Completed
- Conditions
- Psoriasis
- Interventions
- Other: Clinical record review
- Registration Number
- NCT00894777
- Lead Sponsor
- Wyeth is now a wholly owned subsidiary of Pfizer
- Brief Summary
This is an observational, naturalistic, multicenter, retrospective study to describe the therapeutic management of patients with moderate and severe psoriasis under treatment with topical and/or systemic drugs in usual clinical practice in Spain.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 469
Inclusion Criteria
·Over 18 years of age.·Diagnosed with moderate or severe psoriasis.·Initiated treatment with topical and/or systemic treatment between two and five years before enrollment in the study. ·Has a clinical record at the dermatologist office.
Main
Exclusion Criteria
·Currently participating in a clinical study. ·Clinical record lacks minimum data required for observational analysis.
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description 1 Clinical record review Patients with moderate and severe psoriasis under treatment with topical and/or systemic drugs
- Primary Outcome Measures
Name Time Method Descriptive analysis of the therapeutic management of patients with moderate and severe psoriasis under treatment with topical and/or systemic drugs including sequence, doses and duration of treatment. 4 months
- Secondary Outcome Measures
Name Time Method Comparison of therapeutic management depending on patients' disease severity, using absolute and relative frequencies for qualitative variables and centralization and dispersion measures (mean, SD, median, minimum, maximum..) for quantitative variables. 4 months